The Legal 500: Pharmaceutical Advertising Comparative Guide 2022

The latest edition of the Legal 500: Pharmaceutical Advertising Comparative Guide is now online. The aim of this guide is to provide its readers with a pragmatic overview of the law and practice of pharmaceutical advertising law across a variety of jurisdictions.

Each chapter of this guide provides information about the current issues affecting pharmaceutical advertising in a particular country and addresses topics such as self-regulation, press releases, gifts, samples, grants or donations, anti-bribery rules, regulatory authorities and courts, as well as insight and opinion on the most common issues in their respective country.

The Q&A template for each chapter has been provided by Sally Shorthose.

Read our overview of Pharmaceutical Advertising laws and regulations applicable in:

Read the French chapter here
Read the German chapter here
Read the UK chapter here

Latest insights

More Insights
featured image

Greenwashing in the sky? European Authorities Review the Aviation Sector's Sustainability Claims

9 minutes Jun 02 2025

Read More
featured image

Solar canopies on UK car parks: an innovative step along the road to net zero?

4 minutes May 30 2025

Read More
featured image

Turbulent Seas: Navigating Delays & Uncertainty in Dutch Offshore Wind

3 minutes May 30 2025

Read More